222 related articles for article (PubMed ID: 10952481)
1. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine.
Frank T; Bitsch R; Maiwald J; Stein G
Eur J Clin Pharmacol; 2000 Jun; 56(3):251-7. PubMed ID: 10952481
[TBL] [Abstract][Full Text] [Related]
2. Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD).
Frank T; Bitsch R; Maiwald J; Stein G
Int J Clin Pharmacol Ther; 1999 Sep; 37(9):449-55. PubMed ID: 10507244
[TBL] [Abstract][Full Text] [Related]
3. Comparison of erythrocyte transketolase activity with thiamine and thiamine phosphate ester levels in chronic alcoholic patients.
Herve C; Beyne P; Lettéron P; Delacoux E
Clin Chim Acta; 1995 Jan; 234(1-2):91-100. PubMed ID: 7758226
[TBL] [Abstract][Full Text] [Related]
4. Vitamin B(1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay.
Talwar D; Davidson H; Cooney J; St JO'Reilly D
Clin Chem; 2000 May; 46(5):704-10. PubMed ID: 10794754
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Thiamin Diphosphate High-Performance Liquid Chromatography and Erythrocyte Transketolase Assays for Evaluating Thiamin Status in Malaria Patients without Beriberi.
Taylor AJ; Talwar D; Lee SJ; Cox L; Mayxay M; Newton PN
Am J Trop Med Hyg; 2020 Dec; 103(6):2600-2604. PubMed ID: 32996449
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride.
Xie F; Cheng Z; Li S; Liu X; Guo X; Yu P; Gu Z
J Clin Pharmacol; 2014 Jun; 54(6):688-95. PubMed ID: 24399744
[TBL] [Abstract][Full Text] [Related]
7. Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects.
Sheng L; Cao W; Lin P; Chen W; Xu H; Zhong C; Yuan F; Chen H; Li H; Liu C; Yang M; Li X
Drug Des Devel Ther; 2021; 15():1101-1110. PubMed ID: 33727798
[TBL] [Abstract][Full Text] [Related]
8. [Blood transketolase activity and the TDP effect as indices of thiamine body allowance].
Voskoboev AI; Ostrovskii IuM; Grishchenko EA; Averin VA
Vopr Med Khim; 1981; 27(5):690-4. PubMed ID: 7314588
[TBL] [Abstract][Full Text] [Related]
9. [The effect of cocarboxylase treatment on erythrocyte transketolase and blood thiamine in patients with end stage renal disease undergoing maintenance hemodialysis].
Pietrzak I; Czarnecki R; Baczyk K; Młynarczyk M; Kaczmarek M
Przegl Lek; 2000; 57(7-8):369-73. PubMed ID: 11109306
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of erythrocyte thiamin diphosphate as an indicator of thiamin status in man, and its comparison with erythrocyte transketolase activity measurements.
Baines M; Davies G
Ann Clin Biochem; 1988 Nov; 25 ( Pt 6)():698-705. PubMed ID: 3254112
[TBL] [Abstract][Full Text] [Related]
11. The relation between acute changes in the systemic inflammatory response and circulating thiamine and magnesium concentrations after elective knee arthroplasty.
Maguire D; Catchpole A; Sheerins O; Talwar D; Burns A; Blyth M; Shaw A; Jones B; Drury C; Harten J; Smith I; McMillan DC
Sci Rep; 2021 May; 11(1):11271. PubMed ID: 34050237
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability of various thiamine derivatives after oral administration.
Greb A; Bitsch R
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):216-21. PubMed ID: 9587048
[TBL] [Abstract][Full Text] [Related]
13. Thiamine Diphosphate Status and Dialysis-Related Losses in End-Stage Kidney Disease Patients Treated with Hemodialysis.
Jankowska M; Rudnicki-Velasquez P; Storoniak H; Rutkowski P; Rutkowski B; Krzymiński K; Dębska-Ślizień A
Blood Purif; 2017; 44(4):294-300. PubMed ID: 29080898
[TBL] [Abstract][Full Text] [Related]
14. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.
Volvert ML; Seyen S; Piette M; Evrard B; Gangolf M; Plumier JC; Bettendorff L
BMC Pharmacol; 2008 Jun; 8():10. PubMed ID: 18549472
[TBL] [Abstract][Full Text] [Related]
15. Comparative Pharmacokinetic Analysis of Thiamine and Its Phosphorylated Metabolites Administered as Multivitamin Preparations.
Park WS; Lee J; Hong T; Park G; Youn S; Seo Y; Lee S; Han S
Clin Ther; 2016 Oct; 38(10):2277-2285. PubMed ID: 27707509
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative.
Bitsch R; Wolf M; Möller J; Heuzeroth L; Grüneklee D
Ann Nutr Metab; 1991; 35(5):292-6. PubMed ID: 1776825
[TBL] [Abstract][Full Text] [Related]
17. Randomised trial of intravenous thiamine and/or magnesium sulphate administration on erythrocyte transketolase activity, lactate concentrations and alcohol withdrawal scores.
Maguire D; Burns A; Talwar D; Catchpole A; Stefanowicz F; Ross DP; Galloway P; Ireland A; Robson G; Adamson M; Orr L; Kerr JL; Roussis X; Colgan E; Forrest E; Young D; McMillan DC
Sci Rep; 2022 Apr; 12(1):6941. PubMed ID: 35484175
[TBL] [Abstract][Full Text] [Related]
18. Liver, plasma and erythrocyte levels of thiamine and its phosphate esters in rats with acute ethanol intoxication: a comparison of thiamine and benfotiamine administration.
Portari GV; Vannucchi H; Jordao AA
Eur J Pharm Sci; 2013 Mar; 48(4-5):799-802. PubMed ID: 23369791
[TBL] [Abstract][Full Text] [Related]
19. The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity.
Zhang F; Masania J; Anwar A; Xue M; Zehnder D; Kanji H; Rabbani N; Thornalley PJ
Kidney Int; 2016 Aug; 90(2):396-403. PubMed ID: 27198804
[TBL] [Abstract][Full Text] [Related]
20. [Transketolase activity and thiamine diphosphate content in oncological patients].
Trebukhina RV; Tumanov VN; Avdeĭchik LA; Bobko IN; Tsabenko II
Vopr Med Khim; 1983; 29(5):100-3. PubMed ID: 6649520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
